Meeting
2014 ASCO Annual Meeting
Comparison of cisplatin- versus carboplatin-based concurrent chemoradiation for limited-stage small cell lung cancer using SEER-Medicare data.
Authors
Ellen Kim
Case Western Reserve University School of Medicine, Cleveland, OH
Ellen Kim , Tithi Biswas , Siran M. Koroukian , Afshin Dowlati , Neelesh Sharma , Mitchell Machtay
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer - Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Small Cell Lung Cancer
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 7596)
DOI
10.1200/jco.2014.32.15_suppl.7596
Abstract #
7596
Poster Bd #
204
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Annual Meeting
Randomized phase III trial in extensive-disease small cell lung cancer comparing first-line etoposide to topotecan in combination with platinum.
First Author: Morten Mau-Soerensen
Poster
2013 ASCO Annual Meeting
CA184-156: Randomized, multicenter, double-blind, phase III trial comparing the efficacy of ipilimumab (Ipi) plus etoposide/platinum (EP) versus placebo plus EP in patients (Pts) with newly diagnosed extensive-stage disease small cell lung cancer (ED-SCLC).
First Author: Joachim Von Pawel
Poster
2011 ASCO Annual Meeting
Determinants of chemotherapy administration and effects of chemotherapy on survival in elderly patients with small cell lung cancer (SCLC): A SEER-Medicare analysis.
First Author: L. C. Caprario
Poster
2011 ASCO Annual Meeting
Concurrent chemoradiotherapy with or without induction chemotherapy for locally advanced head and neck cancer.
First Author: J. J. Caudell